Vaddepally, R.; Doddamani, R.; Sodavarapu, S.; Madam, N.R.; Katkar, R.; Kutadi, A.P.; Mathew, N.; Garje, R.; Chandra, A.B.
Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge. Biomedicines 2022, 10, 790.
https://doi.org/10.3390/biomedicines10040790
AMA Style
Vaddepally R, Doddamani R, Sodavarapu S, Madam NR, Katkar R, Kutadi AP, Mathew N, Garje R, Chandra AB.
Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge. Biomedicines. 2022; 10(4):790.
https://doi.org/10.3390/biomedicines10040790
Chicago/Turabian Style
Vaddepally, Raju, Rajiv Doddamani, Soujanya Sodavarapu, Narasa Raju Madam, Rujuta Katkar, Anupama P. Kutadi, Nibu Mathew, Rohan Garje, and Abhinav B. Chandra.
2022. "Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge" Biomedicines 10, no. 4: 790.
https://doi.org/10.3390/biomedicines10040790
APA Style
Vaddepally, R., Doddamani, R., Sodavarapu, S., Madam, N. R., Katkar, R., Kutadi, A. P., Mathew, N., Garje, R., & Chandra, A. B.
(2022). Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge. Biomedicines, 10(4), 790.
https://doi.org/10.3390/biomedicines10040790